J Animal Plant Sci
Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance
Telomerase is a special enzyme that can extend the length of telomeres
The Wegovy pill may be a good option if you: want a daily treatment are uncomfortable or have a fear of needles want a semaglutide or GLP-1 treatment have been taking injections and are having injection site reactions, but still want to keep taking weight loss treatment There are several alternatives to Wegovy pills available, including other weight loss tablets and injectable GLP-1 treatments
Other medications, such as metformin, Qsymia (phentermine/topiramate), Contrave (naltrexone/bupropion), and Xenical (orlistat), may also be prescribed as Ozempic alternatives, though they work differently
If weight loss plateaus for more than three to four weeks at therapeutic dose, reassess dietary intake, exercise programming, sleep quality, and stress management before attributing the plateau to the medication alone